News
-
For patient facing mystery illness, the path to a life-changing diagnosis started with a lab test
For seven years, Cid Lopez suffered from a painful mystery illness. Worst of all, after visiting a number of specialists and undergoing multiple surgeries – including several painful spinal operations and a procedure to remove his gallbladder – he was no closer to identifying his condition. But everything changed when a sharp-eyed doctor ordered a very specific set of lab tests, unlocking the answersContinue Reading »... -
ACLA Responds to CMS’s Final Decision Memo for Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer
WASHINGTON, D.C.— In response to the Centers for Medicare and Medicaid Services’ (CMS) Final Decision Memo for Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer (CAG-00450R), ACLA President Julie Khani released the following statement: “We applaud CMS for making important changes to protect Medicare beneficiary access to NGS-based testing for any germline cancer, including breast and ovarian cancer, regardless of stage. BeneficiariesContinue Reading »... -
ACLA Comment Letter on Reconsideration Request for the New PALB2 Full Gene Sequence CPT Code
... -
ACLA Announces Key Staff Promotions
WASHINGTON, D.C.—The American Clinical Laboratory Association (ACLA) today announced the promotions of Thomas Sparkman to Senior Vice President of Government Affairs and Policy, and Andrew Young to Senior Coordinator. “Over the past seven years, Tom has been instrumental in advancing ACLA’s key priorities in front of Congress and the Administration, including recent passage of the Laboratory Access for Beneficiaries (LAB) Act,” said Julie Khani,Continue Reading »... -
ACLA Comments on AKS Proposed Rule
... -
ACLA Comments on Stark Law Proposed Rule
... -
Reply in Support of Plaintiff’s Motion for Summary Judgment and in Opposition To Defendant’s Cross-Motion For Summary Judgement
... -
In Latest Reply Brief, ACLA responds to HHS’s Cross-Motion For Summary Judgment
WASHINGTON, D.C. – As litigation continues in the American Clinical Laboratory Association’s legal challenge against the U.S. Department of Health and Human Services (HHS), ACLA has filed a new reply brief in response to HHS’s cross-motion for summary judgment. The latest brief in ACLA v. Azar reinforces the association’s argument that HHS failed to implement the Protecting Access to Medicare Act (PAMA) as CongressContinue Reading »... -
ACLA Comment Letter on NCCI Policy Manual
... -
ACLA Response to Cures 2.0
...
